Alerts will be sent to your verified email
Verify Email
HESTERBIO
|
Hester Biosciences
|
Bajaj Healthcare
|
SMS Pharmaceuticals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
1.91 % | 0.35 % | 1.61 % |
|
Financials
|
|||
|
5 yr Average ROE
|
10.99 % | 9.93 % | 9.06 % |
|
5yr average Equity Multiplier
|
2.14 | 2.26 | 1.9 |
|
5yr Average Asset Turnover Ratio
|
0.46 | 0.95 | 0.64 |
|
5yr Avg Net Profit Margin
|
11.57 % | 3.65 % | 7.28 % |
|
Price to Book
|
5.15 | 3.09 | 3.25 |
|
P/E
|
43.0 | 30.59 | 28.43 |
|
5yr Avg Cash Conversion Cycle
|
60.38 Days | 15.4 Days | 93.25 Days |
|
Inventory Days
|
100.79 Days | 51.52 Days | 116.73 Days |
|
Days Receivable
|
89.02 Days | 72.17 Days | 93.46 Days |
|
Days Payable
|
127.62 Days | 83.01 Days | 85.64 Days |
|
5yr Average Interest Coverage Ratio
|
6.96 | 7.11 | 4.77 |
|
5yr Avg ROCE
|
11.14 % | 24.2 % | 12.12 % |
|
5yr Avg Operating Profit Margin
|
22.71 % | 16.67 % | 17.98 % |
|
5 yr average Debt to Equity
|
0.75 | 0.86 | 0.53 |
|
5yr CAGR Net Profit
|
-4.4 % | n/a | 9.56 % |
|
5yr Average Return on Assets
|
5.28 % | 5.32 % | 4.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.73 % | 59.19 % | 66.26 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 32.49 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -8.11 % | 2.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 1.66 % | 3.03 % |
|
Hester Biosciences
|
Bajaj Healthcare
|
SMS Pharmaceuticals
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
|
Capex
|
Capex
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|